Company Overview
Snapshot
Founded in June 2011 by Oded Tsamir and Lior Margalit, Omeq Medical operates with 1-10 employees. The company has raised $4.66 million across 4 funding rounds from 3 investors. In May 2023, Omeq Medical received FDA regulatory clearance for its EpiFinder device, a significant milestone for market entry.
Business overview
Omeq Medical develops a single-use smart needle system designed to enhance the safety and accuracy of epidural injections. Its core product, EpiFinder, attaches to standard epidural needles, utilizing a blunted probe to monitor dynamic forces and detect penetration into the epidural space. Once confirmed, a visual signal and safety mechanism protect against inadvertent spinal punctures. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Assistive Devices, serving healthcare providers.
Strategic signal
In May 2023, Omeq Medical secured FDA regulatory clearance for its EpiFinder device, signaling a critical validation of its technology and paving the way for commercialization in the United States. This approval is a strong indicator of the company's readiness to address the market need for improved epidural injection safety and accuracy, positioning it for significant growth and market penetration.
Log in to access full profile ›Company Intelligence Q&A
- What is Omeq Medical's primary product?
- Omeq Medical's primary product is EpiFinder, a single-use smart needle system designed for safe and accurate epidural injections. It provides a visual signal to confirm successful positioning and includes a safety mechanism to prevent spinal puncture.
- When did Omeq Medical receive FDA clearance for its device?
- Omeq Medical received FDA regulatory clearance for its EpiFinder device in May 2023.
- Which investors have participated in Omeq Medical's funding rounds?
- Omeq Medical has received funding from investors including ExitValley and Pharos Medical.
- What was a key strategic development for Omeq Medical in January 2019?
- In January 2019, Omeq Medical signed an investment and commercialization agreement with Pharos Medical, valued at $3 million, to penetrate the Chinese market and establish a production line for its smart epidural device in China.
- What is the total capital raised by Omeq Medical?
- Omeq Medical has raised a total of $4.66 million across its funding rounds.